Structural insight into the glucose-6-phosphate transport by G6PT1 and inhibition mechanism of CGA
Science Advances · 2026
DOI: 10.1126/sciadv.adz8234 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Qihao Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Biomacromolecules (CAS), National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Bio…. Hauptthemen laut MEDLINE: Glucose-6-Phosphate, Monosaccharide Transport Proteins, Symporters. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, The National Key Research and Development Program of China, The Chinese Academy of Sciences Project for Young Scientists in Basic Research.
Abstract (Originalsprache)
Human glucose-6-phosphate transporter 1 (G6PT1) is responsible for transporting glucose-6-phosphate (G6P) into the endoplasmic reticulum (ER), a crucial rate-limiting step in both glycogenolysis and gluconeogenesis. Complete and chronic dysfunction of G6PT1 can lead to the severe metabolic disorder GSD1b, whereas moderate and reversible inhibition contributes to diabetes treatment. We determined the structures of human G6PT1 in its apo state and in complex with the substrate G6P, cosubstrate phosphate, and the inhibitor chlorogenic acid (CGA). Captured in both lumen- and cytosol-facing conformations, these structures reveal the specific mechanism of phosphate-coupled G6P transport. In addition, the CGA-bound G6PT1 complex shows that CGA stabilizes the transporter in the cytosol-facing conformation, inhibiting it by competing with substrate binding and preventing conformational transitions, providing previously unreported insights into G6PT1 inhibition. Our findings provide a structural foundation for understanding the mechanisms of substrate recognition, transport, drug inhibition, and the pharmacology of G6PT1, paving the way to the rational design of potential therapeutic agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Biomacromolecules (CAS), National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
- College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, China.
- Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266100, China.
- School of Life Sciences, Shandong University, Qingdao 266237, China.
ORCID-Profile: Qihao Chen, Pu Yuan, Renjie Li, Rilei Yu, Yan Zhao
Förderung
- National Natural Science Foundation of China
- The National Key Research and Development Program of China
- The Chinese Academy of Sciences Project for Young Scientists in Basic Research
- Brain Science and Brain-like Intelligence Technology, National Science and Technology Major Project
- Young Scientists Fund (A) of the National Natural Science Foundation of China
Zitieren
APA
Chen, Q., Yuan, P., Li, R., Du, X., Yu, R., & Zhao, Y. (2026). Structural insight into the glucose-6-phosphate transport by G6PT1 and inhibition mechanism of CGA. Science Advances. https://doi.org/10.1126/sciadv.adz8234
Vancouver
Chen Q, Yuan P, Li R, Du X, Yu R, Zhao Y. Structural insight into the glucose-6-phosphate transport by G6PT1 and inhibition mechanism of CGA. Science Advances. 2026. doi:10.1126/sciadv.adz8234
BibTeX
@article{Chen2026,
author = {Chen, Qihao and Yuan, Pu and Li, Renjie and Du, Xiaoyue and Yu, Rilei and Zhao, Yan},
title = {Structural insight into the glucose-6-phosphate transport by G6PT1 and inhibition mechanism of CGA},
journal = {Science Advances},
year = {2026},
doi = {10.1126/sciadv.adz8234}
}
EUVIMED